1. Bioinformatics Analysis for Evaluation of the Diagnostic Potentialities of miR-19b, -125b and -205 as Liquid Biopsy Markers of Prostate Cancer.
- Author
-
Bryzgunova, O. E., Lekchnov, E. A., Zaripov, M. M., Yurchenko, Yu. B., Yarmoschuk, S. V., Pashkovskaya, O. A., Rykova, E. Yu., Zheravin, A. A., and Laktionov, P. P.
- Subjects
- *
BIOINFORMATICS , *MICRORNA , *NON-coding RNA , *BIOMARKERS , *PROSTATE cancer patients - Abstract
Presence of tumor-derived cell-free miRNA in biological fluids as well as simplicity and robustness of cellfree miRNA quantification makes them suitable markers for cancer diagnostics. Based on previously published data demonstrating diagnostic potentialities of miR-205 in blood and miR-19b as well as miR-125b in urine of prostate cancer patients, bioinformatics analysis was carried out to follow their involvement in prostate cancer development and select additional miRNA-markers for prostate cancer diagnostics. Studied miRNAs are involved in different signaling pathways and regulate a number of genes involved in cancer development. Five of their targets (CCND1, BRAF, CCNE1, CCNE2, RAF1), according to the STRING database, act as part of the same signaling pathway. RAF1 is regulated by miR-19b and miR-125b, and it was shown to be involved in prostate cancer development by DIANA and STRING databases. Thus, other microRNAs regulating RAF1 expression such as miR-16, -195, -497, and -7 (suggested by DIANA, TargetScan, MiRTarBase and miRDB databases) can potentially be regarded as prostate cancer markers. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF